Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
    Meeting Abstract

    Wang, Y.; Yang, J.; Danussi, C.; Riggins, G.; Sulman, E.; Chan, T.; Huse, J. T.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Previously identified common glioma risk SNPs are associated with familial glioma
    Meeting Abstract

    Ostrom, Q.; Armstrong, G.; Amos, C.; Bernstein, J.; Claus, E.; Eckel-Passow, J.; Il'yasova, D.; Johansen, C.; Lachance, D.; Lai, R.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • PROTECT study: Prophylactic skin toxicity therapy with clindamycin and clobetasol or skin barrier in glioblastoma patients treated with tumor treating fields
    Meeting Abstract

    Lacouture, M.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • The Ivy Glioblastoma Patient Atlas: A novel clinical and radio-genomics resource for early phase clinical trial design and interpretation
    Meeting Abstract

    Ligon, K.; Lupo, J.; Molinaro, A.; Block, S.; Charbonneau, S.; Geduldig, J.; Stemmer-Rachamimov, A.; DeAngelis, L.; Yong, W.; Schultz, N.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Phase 1 study of AG-881, an inhibitor of mutant IDH1 and IDH2: Results from the recurrent/progressive glioma population
    Meeting Abstract

    Mellinghoff, I.; Penas-Prado, M.; Peters, K.; Cloughesy, T.; Burris, H.; Maher, E.; Janku, F.; Cote, G.; De La Fuente, M.; Clarke, J.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Integrated clinical experience with ONC201 in previously-treated H3 K27M-mutant glioma patients
    Meeting Abstract

    Chi, A.; Arrillaga-Romany, I.; Gardner, S.; Wen, P.; Batchelor, T.; Hall, M.; Odia, Y.; Khatua, S.; Zaky, W.; McGovern, S.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Leptomeningeal melanoma metastasis presenting as intraventricular and subarachnoid hemorrhage
    Meeting Abstract

    Graham, M.; Jagannathan, R.; Rubens, E.; Wolchok, J.; Wu, S.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Intrathecal (IT) traztuzumab (T) for the treatment of leptomeningeal metastases (LM) in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) cancer: A multicenter phase 1/2 study
    Meeting Abstract

    Kumthekar, P.; Gradishar, W.; Lin, N.; Pentsova, E.; Groves, M.; Jeyapalan, S.; Melisko, M.; Grimm, S.; Lassman, A. B.; Raizer, J.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of lung cancer patients with leptomeningeal metastases in the targeted therapy era
    Meeting Abstract

    Nevel, K.; Cowan, A.; Reiner, A.; Ogilvie, S.; Skakodub, A.; Distefano, N.; Pentsova, E.; Boire, A.
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Updated results of a phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM
    Meeting Abstract

    Lim, M.; Ye, X.; Nabors, L. B.; Piotrowski, A.; Ahluwalia, M.; Desai, A.; Walbert, T.; Fisher, J.; Desideri, S.; Sims, M.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save